headline
Bio-Rads Management to Participate in Fireside Chat During RBC Capital Markets Global Healthcare Conference
Analysts Estimate Bio-Rad Laboratories (BIO) to Report a Decline in Earnings: What to Look Out for
Bio-Rad Announces Life Science Group Management Changes
Bio-Rad Laboratories (BIO) to Post Q1 Earnings: What Awaits?
"Bio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024"
Bio-Rad (BIO) Hurt by Softness in BioPharma and Competition
Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay
Bio-Rads Chief Operating Officer Andrew Last to Retire
25 Countries with Highest Malaria Death Rates
"Bio-Rad Appoints Roop K. Lakkaraju Executive Vice President, Chief Financial Officer"
"Bio-Rad (BIO) Suffers due to BioPharma Softness, Stiff Competition"
Billionaires Mario Gabelli and Mason Hawkins Love These 5 Stocks
Bio-Rad to Participate in Fireside Chat During Citi's 2024 Unplugged Medtech and Life Sciences Access Day
Bio-Rad Reports Fourth-Quarter and Full-Year 2023 Financial Results
Bio-Rad Laboratories (BIO) to Post Q4 Earnings: What Awaits?
"Bio-Rad to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, February 15, 2024"
Bio-Rads Management to Host Investor Meetings at J.P. Morgans 42nd Annual Healthcare Conference
5 Beaten Down Stocks Billionaires Are Crazy About
"Bio-Rad Laboratories, Inc. (NYSE:BIO) Q3 2023 Earnings Call Transcript"
Bio-Rad Reports Third-Quarter 2023 Financial Results
"Bio-Rad to Report Third Quarter 2023 Financial Results on Thursday, October 26, 2023"
New Strong Sell Stocks for September 19th
Bio-Rad to Participate in Fireside Chat During Wells Fargos 2023 Healthcare Conference
Bio-Rad Reports Second-Quarter 2023 Financial Results
Bio-Rad and QIAGEN Announce Patent Settlement and Cross-Licensing Agreement
Bio-Rad Announces New Share Repurchase Program
"Bio-Rad to Report Second Quarter 2023 Financial Results on Thursday, August 3, 2023"
Bio-Rad Publishes Corporate Sustainability Report for 2022
Wells Fargo Predicts up to 125% Rally for These 2 Stocks  Heres Why They Have Solid Upside
BIO: Lowering target price to $385.00
Bio-Rad to Present Company Overview at Jefferies Healthcare Conference
Bio-Rad to Participate in Fireside Chat During 2023 RBC Capital Markets Global Healthcare Conference
Bio-Rad Reports First-Quarter 2023 Financial Results
BIO: Raising target price to $458.00
"Bio-Rad to Report First Quarter 2023 Financial Results on Thursday, May 4, 2023"
"Bio-Rad to Participate in Citis 2023 Healthcare Services, MedTech, Tools & HCIT Conference"
Bio-Rad Reports Fourth-Quarter and Full-Year 2022 Financial Results
Element Biosciences and Bio-Rad Partner to Deliver Seamless RNA Sequencing Workflow Between Element's AVITI System and Bio-Rad's SEQuoia Express and SEQuoia Complete Stranded RNA Library Prep Kits
CytekÂ® Biosciences Partners with Bio-Rad to Expand Reagent Portfolios
"Bio-Rad to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, February 16, 2023"
Bio-Rad to Present Company Overview at J.P. Morgan 41st Annual Healthcare Conference
"Bio Rad Has Almost 40% Upside On Revenue Acceleration And Margin Improvement, Analyst Says"
"Beaten-Down Bio-Rad Laboratories Shows Improvement, but Be Patient"
Retirement Stock Portfolio: 11 Safe Healthcare Stocks to Consider
15 Biggest Medical Device Companies in the World
The 7.7% return this week takes Bio-Rad Laboratories' (NYSE:BIO) shareholders five-year gains to 49%
Bio-Rad To Participate in Fireside Chat During Credit Suisses 31st Annual Healthcare Conference
"Bio-Rad (BIO) Q3 Earnings Surpass Estimates, Margins Down"
Bio-Rad Laboratories (BIO) Surpasses Q3 Earnings Estimates
Bio-Rad Reports Third-Quarter 2022 Financial Results
"Medical Device Stocks' Q3 Earnings on Oct 27: LH, BIO & More"
Bio-Rad (BIO) to Report Q3 Earnings: What's in the Cards?
"Bio-Rad to Report Third Quarter 2022 Financial Results on Thursday, October 27, 2022"
Top 10 Healthcare Stocks to Buy
"A Look At The Fair Value Of Bio-Rad Laboratories, Inc. (NYSE:BIO)"
Why Bio-Rad Laboratories' Rumored $10 Billion Qiagen Buyout Looks Unlikely
"Bio-Rad Laboratories, Qiagen Mull Merger Of Equals"
Biotech Firms Bio-Rad and Qiagen Discuss Major Merger
Bio-Rad Laboratories in Talks to Combine With Qiagen
East Bay life sciences company reportedly in talks with Qiagen in $10 billion deal
Diagnostics firm Bio-Rad in talks to merge with Qiagen - WSJ
BD's (BDX) Latest Monkeypox PCR Assay Commercially Available
Patterson Companies (PDCO) Q1 Earnings & Sales Miss Estimates
Cooper Companies (COO) Q3 Earnings & Revenues Top Estimates
What's in Store for Patterson Companies (PDCO) in Q1 Earnings?
Cooper Companies (COO) to Post Q3 Earnings: What's in Store?
Here's Why You Should Invest in Bio-Rad (BIO) Stock Now
4 Stocks to Watch Amid Recovering Medical Products Industry
Levin Easterly Partners Latest Portfolio: Top 10 Stock Picks
12 Best Healthcare Stocks To Buy Now
Bio-Rad Acquires Curiosity Diagnostics
"Bio-Rad (BIO) Q2 Earnings Surpass Estimates, Gross Margin Up"
Bio-Rad Laboratories (BIO) Surpasses Q2 Earnings and Revenue Estimates
Bio-Rad Reports Second-Quarter 2022 Financial Results
Medical Device Stocks to Watch for Earnings on Jul 28
Bio-Rad (BIO) to Report Q2 Earnings: What's in the Cards?
"Bio-Rad to Report Second Quarter 2022 Financial Results on Thursday, July 28, 2022"
10 Stocks Billionaire Ken Fisher May Never Sell
"Is Now The Time To Look At Buying Bio-Rad Laboratories, Inc. (NYSE:BIO)?"
Investors are Watching These 10 Biotech Stocks
Bio-Rad Publishes Corporate Sustainability Report
Is Bio-Rad Laboratories (NYSE:BIO) Using Too Much Debt?
Here's Why You Should Invest in Bio-Rad (BIO) Stock Now
What's in Store for Patterson Companies' (PDCO) Q4 Earnings?
"Bio-Rad (BIO) Immunohematology Arm Recovers, New Launches Aid"
Why Is NuVasive (NUVA) Up 6.3% Since Last Earnings Report?
"Cooper Companies (COO) Q2 Earnings Miss Estimates, Revenues Top"
Ebay Tops BofA List of Companies with High Free Cash Flow
The 4.8% return this week takes Bio-Rad Laboratories' (NYSE:BIO) shareholders five-year gains to 140%
Medtronic's (MDT) Q4 Earnings and Revenues Lag Estimates
"Change Healthcare (CHNG) Q4 Earnings Miss Estimates, Revenues Top"
Cooper Companies (COO) to Post Q2 Earnings: What's in Store?
Veeva Systems (VEEV) to Post Q1 Earnings: What's in Store?
Wall Street Analysts Believe Bio-Rad (BIO) Could Rally 53%: Here's is How to Trade
"If You Invested $1000 in Bio-Rad Laboratories 10 Years Ago, This Is How Much You'd Have Now"
"Estimating The Intrinsic Value Of Bio-Rad Laboratories, Inc. (NYSE:BIO)"
"Bio-Rad (BIO) Q1 Earnings Surpass Estimates, Margins Up"
Bio-Rad Laboratories (BIO) Surpasses Q1 Earnings and Revenue Estimates
Bio-Rad Reports First-Quarter 2022 Financial Results
"Medical Products Stocks' Earnings on Apr 28: TMO, BIO & More"
